Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Point Biopharma Global Inc (NQ: PNT ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Point Biopharma Global Inc Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment November 29, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NASDAQ:MRTX),(NYSE:LLY),(NASDAQ:PNT) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race October 17, 2023 Major pharmaceutical companies are continuing to make substantial acquisitions in the field of oncology, sparking enthusiasm in the market. Bristol Myers Squibb (NYSE:BMY) just announced its plan to... Via PressReach POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT October 06, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS) October 03, 2023 From Brodsky & Smith LLC Via GlobeNewswire PNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of POINT Biopharma Global, Inc. Is Fair to Shareholders October 03, 2023 From Halper Sadeh LLC Via Business Wire Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer April 24, 2023 From Lantheus Holdings, Inc.; POINT Biopharma Global Inc. Via GlobeNewswire Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 November 14, 2022 From Lantheus Holdings, Inc. Via GlobeNewswire NorthStar Medical Radioisotopes and POINT Biopharma Announce Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 September 08, 2021 From NorthStar Medical Radioisotopes, LLC Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
